FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

INDIAGLYCO

694.05
-12.5 (-1.77%)
Updated 03:28 23/07 IST

INDIAGLYCO Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 9,997 for INDIAGLYCO
Disclaimer
100% Bullish
0% Bearish

INDIAGLYCO Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See INDIAGLYCO Share Price Targets >>

INDIAGLYCO Ratings

Long term INDIAGLYCO rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live INDIAGLYCO message board: Is INDIAGLYCO buy or sell? Should I buy INDIAGLYCO shares? Why are INDIAGLYCO shares falling? Should I invest in INDIAGLYCO stock?

  1. Home
  2. INDIAGLYCO Forum

INDIAGLYCO Share Price Discussion

K
Reputation: 12,179 • Jul 15 11:59 AM

INDIA GLYCOLS: OMC WILL BUY 300 CR LITRE ETHANOL #INDIAGLYCO
Like
Reply

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹739.5
Price@Trade
₹739.5
Target Price
₹770
Stop Price
₹710
Valid Till
Aug 13, 2021 3:20 AM
Margin
₹7,395 approx for 10 Qty
Status
Active
Like
Reply
swap_vert
Trade

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹769
Price@Trade
₹769
Target Price
₹1,072
Stop Price
₹612
Valid Till
Jul 13, 2022 3:20 AM
Margin
₹9,997 approx for 13 Qty
Status
Active

Like
Reply
swap_vert
Trade
K
Reputation: 144 • Jul 13 4:36 AM
Like
Reply
K
Reputation: 144 • Jul 13 4:34 AM
Like
Reply
N
Reputation: 15,412 • Jul 13 5:41 AM
India Glycols bets on liquor, value-added chemicals as it weans of commoditised products
The chemicals maker is betting big on its liquor and nutraceuticals businesses, as well as other value-added specialty chemicals.
The Economic Times
Like
Reply
N
Reputation: 15,412 • Jul 7 6:16 AM
India Glycols and Swiss Clariant formalise new joint venture company
Called Clariant IGL Specialty Chemicals Private Limited, the joint venture will be owned 49% by IGL and its subsidiary and 51% by Clariant. The stock of IGL closed 2.61% higher on the NSE at Rs 699 per share against a flattish Nifty.
The Economic Times
Like
Reply
D
Reputation: 1,296 • Jul 6 4:07 AM

INDIAGLYCO - 3765481
#INDIAGLYCO did not get to the lower level as expected. Entered as the price action was favourable.
Like
Reply
U
Reputation: 0 • Jul 5 6:57 AM

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹685
Price@Trade
₹686
Target Price
₹745
Stop Price
₹640
Valid Till
Jul 6, 2021 3:20 AM
Margin
₹68,500 approx for 100 Qty
Status
Exited
Exit Price
₹707.85
Net P&L
+₹2,285 (+3.34%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 5 7:04 AM

Update
Trade Entered
Entry Price
₹685
Uppi @uppi-H1xBJLoNu
Jul 6 2:54 AM

Update
Exited
Exit Price
₹707.85
Net P&L
+₹2,285 (+3.34%)

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹689.35
Price@Trade
₹689.35
Target Price
₹840
Stop Price
₹650
Valid Till
Aug 5, 2021 3:20 AM
Margin
₹999,557.5 approx for 1450 Qty
Status
Exited
Exit Price
₹717.75
Net P&L
+₹41,180 (+4.12%)
Like
Reply (1)
swap_vert
Trade
See all replies
Neeraj Rana @neerajrana
Jul 6 5:12 AM

Update
Exited
Exit Price
₹717.75
Net P&L
+₹41,180 (+4.12%)
K
Reputation: 144 • Jul 2 2:47 AM
Like
Reply
K
Reputation: 144 • Jul 1 8:59 AM
Like
Reply

Fresh call for lion hearts
India glycol above 728 can be blast of decade.
Support at 650 levels.
Use brains and then only trade.
Here RR is not favourable.
But dips upto 659 can be an opportunity
Like
Reply (1)
See all replies

Kissed 763.7
D
Reputation: 1,296 • Jul 1 4:20 AM
Dr K in INDIAGLYCO
#INDIAGLYCO posted on 21st June MP: 540. Up alm...

540》》》648 (+20%)
21st June - 01st July
Could book around these levels OR
Shift the SL to 619 (for a tight one) OR place it around 595 and re-enter after some favorable price action. Depends on how you want to trade it. For those who have the stomach to hold through th...
Read more...
1
Reply
S
Reputation: 0 • Jun 29 3:25 AM
Like
Reply
S
Reputation: 0 • Jun 29 3:13 AM
Like
Reply

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹619
Price@Trade
₹601.65
Target Price
₹650
Stop Price
₹590  ₹619
Valid Till
Jul 28, 2021 3:20 AM
Margin
₹61,900 approx for 100 Qty
Status
Target Achieved
Exit Price
₹652
Net P&L
+₹3,300 (+5.33%)

Like
Reply (3)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jun 29 2:52 AM

Update
Trade Entered
Entry Price
₹619
Ashwin murali @ashwinpm
Jun 29 3:06 AM

Update
Stoploss Trailed
Price @ Update
₹629.5
Original SL
₹590
New SL
619.0
TrackerBot @trackerbot
Jun 30 2:46 AM

Update
Target Achieved
Exit Price
₹652
G
Reputation: 48 • Jun 28 7:56 AM

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹611
Price@Trade
₹611
Target Price
₹650
Stop Price
₹595
Valid Till
Jun 28, 2021 3:20 AM
Margin
₹611,000 approx for 1000 Qty
Status
Validity Over
Exit Price
₹598
Net P&L
-₹13,000 (-2.13%)

Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jun 28 8:50 AM

Update
Validity Over
Exit Price
₹598
Net P&L
-₹13,000 (-2.13%)

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹615
Price@Trade
₹615.7
Target Price
₹650
Stop Price
₹590
Valid Till
Jul 28, 2021 3:20 AM
Margin
₹246,000 approx for 400 Qty
Status
Target Achieved
Exit Price
₹652
Net P&L
+₹14,800 (+6.02%)

Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jun 28 5:11 AM

Update
Trade Entered
Entry Price
₹615
TrackerBot @trackerbot
Jun 30 2:46 AM

Update
Target Achieved
Exit Price
₹652

Type
Buy
Instrument
INDIAGLYCO
Entry Price
₹624
Price@Trade
₹624
Target Price
₹868
Stop Price
₹496
Valid Till
Jun 28, 2022 3:20 AM
Margin
₹10,608 approx for 17 Qty
Status
Exited
Exit Price
₹643.65
Net P&L
+₹334.05 (+3.15%)
Like
Reply (1)
swap_vert
Trade
See all replies
Ketul Vyas @KetulVyas
Jun 29 3:17 AM

Update
Exited
Exit Price
₹643.65
Net P&L
+₹334.05 (+3.15%)
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • INDIAGLYCO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization865.8
    Enterprise Value1,549.08
    Price to Earnings14.29
    Price to Book Value0.81
    Return on Capital Employed0.16
    Return on Equity0.1
    Face Value10
    Dividend Yield0.01
  • INDIAGLYCO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 23710713.4692695.5
    Jul 22694715694706.55
    Jul 20715.45718.7681.35691.3
    Jul 19707.05730.8707.05714.05
    Jul 16735737.7716.15719.8
  • INDIAGLYCO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹688.9
    30 Day Moving Average₹639.18
    50 Day Moving Average₹585.89
    100 Day Moving Average₹531.09
    200 Day Moving Average₹429.95
  • INDIAGLYCO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue3,0272,473.410.22
    Operating Profit325236.520.37
    Profit Before Tax14853.961.74
    Net Income9844.521.2
  • INDIAGLYCO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,0749400.14
    Total Liabilities2,6412,697-0.02
    Total Assets3,7153,6390.02
  • INDIAGLYCO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity487302.430.61
    Cash from Investing Activity-145-40.772.56
    Cash from Financing Activity-342-260.810.31
    Net Cash FlowNA0.85-1
  • INDIAGLYCO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.01
    Return on Equity0.10.05
    Return on Capital Employed0.160.1
  • INDIAGLYCO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.18
    3 Year CAGR Growth in Operating Profit3.12
    3 Year CAGR Growth in EBIDTA1.72
    3 Year CAGR Growth in Net Income2.6
    3 Yr CAGR Growth - Diluted EPS2.6
  • INDIAGLYCO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.09
    5 Year CAGR Growth in Operating Profit-0.12
    5 Year CAGR Growth in EBIDTA-0.12
    5 Year CAGR Growth in Net Income-0.19
    3 Yr CAGR Growth - Diluted EPS-0.19
  • INDIAGLYCO - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 13 5:41 AM
    India Glycols bets on liquor, value-added chemicals as it weans of commoditised products
    The Economic Times
    NewsBot
    Jun 28 4:36 AM
    India Glycols shares surge 12% after manifold jump in Q4 profit
    The Economic Times
    NewsBot
    Apr 23 1:16 AM
    Centralised oxygen supply plan ready for 19 states, UTs
    The Economic Times
    NewsBot
    Mar 12 5:46 AM
    Swiss chemical company Clariant AG forms JV with India Glycols
    The Economic Times
    NewsBot
    Aug 14, 2020 6:13 AM
    India Glycols Standalone June 2020 Net Sales at Rs 385.53 crore, down 55.51% Y-o-Y
    Moneycontrol
    NewsBot
    Aug 14, 2020 5:58 AM
    India Glycols Consolidated June 2020 Net Sales at Rs 385.62 crore, down 55.52% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 25, 2020 3:08 AM
    India Glycols Standalone March 2020 Net Sales at Rs 909.02 crore, up 3.82% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 25, 2020 3:03 AM
    India Glycols Consolidated March 2020 Net Sales at Rs 912.34 crore, up 4.2% Y-o-Y
    Moneycontrol
    NewsBot
    Oct 18, 2019 1:38 AM
    Stocks in the news: Reliance Industries, Ambuja Cements, Aurobindo Pharma, KPR Mill
    Moneycontrol
    NewsBot
    Aug 12, 2019 6:53 AM
    India Glycols Standalone June 2019 Net Sales at Rs 866.64 crore, up 13.39% Y-o-Y
    moneycontrol.com
  • INDIAGLYCO - Related Communities

    keyboard_arrow_down
    UPL Ltd. NSE: UPL | BSE: 512070 | ISI...
    Tata Chemicals Ltd. NSE: TATACHEM | B...
    Pidilite Industries Ltd. NSE: PIDILIT...
    Deepak Nitrite Ltd. NSE: DEEPAKNTR | ...
    Aarti Industries Ltd. NSE: AARTIIND |...
    Godrej Industries Ltd. NSE: GODREJIND...
    Rallis India Ltd. NSE: RALLIS | BSE: ...
    Himadri Speciality Chemical Ltd. NSE:...
    PI Industries Ltd. NSE: PIIND | BSE: ...
    Navin Fluorine International Ltd. NSE...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020